Site icon NEWS4EXCHANGE

Shilpa Medicare Announces Positive Phase 3 Results for OERIS™ — A Novel Once-Weekly Ondansetron Extended-Release Injection for Chemotherapy-Induced Nausea and Vomiting (CINV)

gopalkumarthakur@gmail.com

Related posts:

  1. PUNJAB CM TAKES STOCK OF RELIEF AND RESCUE MEASURES IN FLOOD AFFECTED HOSHIARPUR DISTRICT
  2. Every flood victim will get compensation within 45 days: CM Mann
  3. Herbalife Strengthens Enduring Partnership with IRONMAN 70.3 GOA, INDIA for its Fifth Edition
  4. Air Serbia and Loyalty Juggernaut Partner to Launch a Next-Generation Frequent Flyer Program
Exit mobile version